As of Dec 06
| -0.03 / -2.00%|
The 5 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 10.00 and a low estimate of 5.00. The median estimate represents a +308.16% increase from the last price of 1.47.
The current consensus among 5 polled investment analysts is to Buy stock in Anthera Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.